New Data Gives Hope for a Limb-Girdle Muscular Dystrophy Gene Therapy
According to a story from BioPharma Dive, the drug company Sarepta Therapeutics is pushing forward with its plans to develop a gene therapy for limb-girdle muscular dystrophy (LGMD). The company…